🇺🇸 FDA
Patent

US 6068854

Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form

expired A61KA61K9/2063

Quick answer

US patent 6068854 (Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form) held by ALFATEC-Pharm GmbH expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
ALFATEC-Pharm GmbH
Grant date
Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K9/2063